Cargando…

Lack of Association between Serum Interleukin-23 and Interleukin-27 Levels and Disease Activity in Patients with Active Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease characterized by the production of multiple autoantibodies, resulting in tissue and organ damage. Recent studies have revealed that interleukin-23 (IL-23) and interleukin-27 (IL-27) may be therapeutically relevant in selecte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pawlak-Buś, Katarzyna, Schmidt, Wiktor, Leszczyński, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537777/ https://www.ncbi.nlm.nih.gov/pubmed/34682911 http://dx.doi.org/10.3390/jcm10204788

Ejemplares similares

Current treatment of systemic lupus erythematosus: a clinician's perspective
por: Katarzyna, Pawlak-Buś, et al.
Publicado: (2023)

Vocal cords palsy in systemic lupus erythematosus patient: diagnostic and therapeutic difficulties
por: Leszczynski, Piotr, et al.
Publicado: (2012)

2022 Systemic lupus erythematosus remission in clinical practice. Message for Polish rheumatologists
por: Pawlak-Buś, Katarzyna, et al.
Publicado: (2022)

Serum Interleukin-23 in Polish Patients with Systemic Lupus Erythematosus: Association with Lupus Nephritis, Obesity, and Peripheral Vascular Disease
por: Fischer, Katarzyna, et al.
Publicado: (2017)

Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience
por: Schmidt, Wiktor, et al.
Publicado: (2023)

Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus
por: Wang, Hongxu, et al.
Publicado: (2016)

Elevated Serum Interleukin-34 Level in Patients with Systemic Lupus Erythematosus Is Associated with Disease Activity
por: Xie, Huan Huan, et al.
Publicado: (2018)

Serum interleukin-6 level is correlated with the disease activity of systemic lupus erythematosus: a meta-analysis
por: Ding, Jianwen, et al.
Publicado: (2020)

Clinical associations of serum interleukin-17 in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2013)

Work instability and associated factors among patients with rheumatoid arthritis in Greater Poland
por: Schmidt, Wiktor, et al.
Publicado: (2020)

Serum interleukin-17 levels are associated with nephritis in childhood-onset systemic lupus erythematosus
por: de Oliveira Peliçari, Karina, et al.
Publicado: (2015)

Serum and Urinary Interleukin-6 in Assessment of Renal Activity in Egyptian Patients with Systemic Lupus Erythematosus
por: EL-Shereef, Rawhya R., et al.
Publicado: (2016)

Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus
por: Brilland, Benoit, et al.
Publicado: (2021)

Autologous hematopoietic stem cell transplant for progressive diffuse systemic sclerosis: procedural success and clinical outcome in 5-year follow-up
por: Pawlak-Buś, Katarzyna, et al.
Publicado: (2019)

Association between interleukin 12B and interleukin 23R gene polymorphisms and systemic lupus erythematosus: a meta-analysis
por: Jung, Jae Hyun, et al.
Publicado: (2022)

High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damage
por: Korkosz, Mariusz, et al.
Publicado: (2013)

Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus
por: Rezaieyazdi, Zahra, et al.
Publicado: (2021)

Interleukin-17A and interleukin-23 in morphea
por: Dańczak-Pazdrowska, Aleksandra, et al.
Publicado: (2012)

Decreased levels of interleukin 27 in the serum of vitiligo patients()()
por: Hosseini, Saeed Malek, et al.
Publicado: (2020)

Utility of serum ferritin and soluble interleukin-2 receptor as markers of disease activity in childhood systemic lupus erythematosus
por: Almutairi, Nora, et al.
Publicado: (2020)

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus
por: Mende, Rachel, et al.
Publicado: (2018)

Increased interleukin-23 receptor(+ )T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
por: Puwipirom, Hathaipat, et al.
Publicado: (2010)

Kikuchi-Fujimoto disease associated with primary Sjögren’s syndrome – literature review based on a case report
por: Wiśniewska, Katarzyna, et al.
Publicado: (2020)

Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus
por: Pan, Qingjun, et al.
Publicado: (2017)

Increased Serum Interleukin-9 Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenic Role or Just an Epiphenomenon?
por: Dantas, Andréa Tavares, et al.
Publicado: (2015)

Elevated serum interleukin-23 levels in ankylosing spondylitis patients and the relationship with disease activity
por: Ugur, Mahir, et al.
Publicado: (2015)

Adult-onset Still's disease as a mask of Hodgkin lymphoma
por: Dudziec, Ewa, et al.
Publicado: (2015)

Low-dose interleukin-2 therapy in systemic lupus erythematosus
por: La Cava, Antonio
Publicado: (2023)

Association of Serum T cell Immunoglobulin Domain and Mucin-3 and Interleukin-17 with Systemic Lupus Erythematosus
por: Jin, Lairun, et al.
Publicado: (2018)

Significance of Interleukin 23 in Systemic Lupus Patients: Relation to Disease Activity and Damage Indices
por: Haroon, Maysa M, et al.
Publicado: (2023)

Commentary: Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus
por: Poddighe, Dimitri, et al.
Publicado: (2017)

Serum interleukin-23 levels: relation to depression, anxiety, and disease activity in psoriatic arthritis patients
por: Tabra, Samar Abdalhamed, et al.
Publicado: (2022)

Serum Interleukin-27 Level in Different Clinical Stages of Lung Cancer
por: Babadi, Akbar Soleimani, et al.
Publicado: (2019)

Interleukin-21: A New Mediator of Inflammation in Systemic Lupus Erythematosus
por: Sarra, Massimiliano, et al.
Publicado: (2010)

Hypomethylation of interleukin 6 correlates with renal involvement in systemic lupus erythematosus
por: Tang, Chun, et al.
Publicado: (2014)

T Cells, Interleukin-2 and Systemic Lupus Erythematosus—From Pathophysiology to Therapy
por: Mak, Anselm
Publicado: (2022)

Correlation between circulating interleukin-18 level and systemic lupus erythematosus: a meta-analysis
por: Xiang, Mengmeng, et al.
Publicado: (2021)

Correlation of plasma interleukin-18 concentration and severity of renal involvement and disease activity in systemic lupus erythematosus
por: Jafari-Nakhjavani, Mohammad Reza, et al.
Publicado: (2016)

The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus
por: Thanadetsuntorn, Chokchai, et al.
Publicado: (2018)

Contribution of interleukin 27 serum level to pathogenesis and prognosis in children with immune thrombocytopenia
por: Hassan, Tamer, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jv75ff9b5o1n2dbd54mlud2qbe